These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8194840)

  • 1. Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level.
    Parker D; Alison DL; Barnard DL; Child JA; Dovey G; Farish J; Norfolk DR; O'Brien CJ; Parapia LA; Sharp J
    Hematol Oncol; 1994; 12(1):15-27. PubMed ID: 8194840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulins in non-Hodgkin's lymphoma patients.
    Planinc-Peraica A; Kolonić SO; Radić-Kristo D; Dominis M; Jaksić B
    Coll Antropol; 2010 Jun; 34(2):407-11. PubMed ID: 20698110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Centroblastic and centrocytic centroblastic malignant lymphomas, predominantly splenic (or primary of the spleen). Anatomo-clinical study of 17 cases].
    Diebold J; Kanavaros P; Audouin J; Bernadou A; Zittoun R
    Bull Cancer; 1987; 74(4):437-53. PubMed ID: 3663966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
    Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
    Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
    Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
    Heinz R; Hanak H; Stacher A
    Klin Wochenschr; 1985 Jul; 63(14):619-26. PubMed ID: 3839867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].
    Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
    Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
    Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
    Johnson PW; Whelan J; Longhurst S; Stepniewska K; Matthews J; Amess J; Norton A; Rohatiner AZ; Lister TA
    Br J Cancer; 1993 Apr; 67(4):792-7. PubMed ID: 8471438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group].
    Sýkorová A; Belada D; Smolej L; Pytlík R; Benesová K; Vásová I; Papajík T; Sálek D; Procházka V; Matuska M; Brejcha M; Kubácková K; Kabícková E; Móciková H; Campr V; Trnený M;
    Klin Onkol; 2010; 23(3):146-54. PubMed ID: 20608324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects of malignant non-Hodgkin's-lymphomas with reference to Kiel classification: centrocytic lymphoma, centroblastic-centrocytic lymphoma, lymphoblastic lymphoma, immunoblastic lymphoma].
    Brittinger G; Bartels H; Bremer K; Dühmke E; Gunzer U; König E; Stein H
    Hamatol Bluttransfus; 1976; 18():211-23. PubMed ID: 786810
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
    Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
    Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens.
    Arber DA; George TI
    Am J Surg Pathol; 2005 Dec; 29(12):1549-57. PubMed ID: 16327427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary splenic presentation of malignant lymphoma and related disorders. A study of 49 cases.
    Kraemer BB; Osborne BM; Butler JJ
    Cancer; 1984 Oct; 54(8):1606-19. PubMed ID: 6548171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
    Ding SL; Ko WS; Hwang WS
    J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases.
    Heyning FH; Hogendoorn PC; Kramer MH; Hermans J; Kluin-Nelemans JC; Noordijk EM; Kluin PM
    Leukemia; 1999 Dec; 13(12):2094-8. PubMed ID: 10602434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.